Stock listing

NASDAQ:ALDR Alder BioPharmaceuticals Inc Stock

Follow Alder BioPharmaceuticals Inc into a list and get an email when it puts out news.

Last close · NASDAQ:ALDR

$18.88 USD

Close on Oct 21, 2019 · No longer trades

May 8, 2014 to last close +88.2% · weekly closes, May 8, 2014 – Oct 21, 2019
Lowest – highest close
$8.59 – $52.97 USDSince May 8, 2014 · lowest Sep 3, 2019 · highest Jun 30, 2015

Delisted NASDAQ:ALDR no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:ALDR
Asset type
Stock
Exchange
NASDAQ
Currency
USD

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Robert Azelby
Other companies: Tango Therapeutics, Inc. (Chairman; Former President and CEO, Eliem Therapeutics, Inc. · Since at least Jun 19, 2026); Autolus Therapeutics plc (Director · Since at least Mar 18, 2026); Terns Pharmaceuticals, Inc. (Director · Since at least Feb 20, 2025); Cardinal Health, Inc. (Director · Since at least Mar 1, 2024); ADC Therapeutics SA (Director · Since at least Jan 2, 2024); Aduro Biotech Inc (Director · Apr 10, 2023 – Aug 11, 2023 · Past); Climb Bio, Inc. (President & CEO, Director · Aug 9, 2021 – Oct 31, 2022 · Past); Immunomedics Inc (Director · Feb 26, 2020 – Oct 23, 2020 · Past); Clovis Oncology Inc (Director · Oct 11, 2018 – Jun 10, 2021 · Past); Cascadian Therapeutics Inc (Director · Mar 31, 2017 – Mar 9, 2018 · Past); Juno Therapeutics Inc (EVP & Chief Commercial Officer · Nov 1, 2015 – Mar 5, 2018 · Past)
President and CEO, Director · Jun 13, 2018 – Oct 22, 2019 · Past
Erin Lavelle
Other companies: Avalyn Pharma Inc. (Director · Since at least Apr 29, 2026); Jade Biosciences, Inc. (Director · Since at least Apr 28, 2025); Neurogene Inc. (Director · May 12, 2022 – Jun 8, 2023 · Past); Climb Bio, Inc. (COO & CFO · Aug 9, 2021 – Oct 31, 2022 · Past)
Chief Operating Officer · Apr 16, 2018 – Oct 22, 2019 · Past
Paul Carter
Other companies: Immatics N.V. (Non-Executive Director · Since at least Mar 18, 2026); Mallinckrodt Inc (Director · May 16, 2018 – Jun 16, 2022 · Past); Gilead Sciences, Inc. (EVP Commercial Ops · Jul 1, 2015 – Aug 1, 2016 · Past)
Director · Sep 28, 2015 – Oct 22, 2019 · Past
Alan Bruce Montgomery
Other companies: Xencor, Inc. (Director · Since at least Jun 23, 2016); CytoDyn Inc. (Director · Jun 1, 2016 – Jul 12, 2018 · Past)
Director · May 26, 2016 – Oct 22, 2019 · Past
Jeffrey T L Smith
Other companies: Zymeworks Inc. (EVP & Chief Medical Officer · Since at least Jan 3, 2024)
Managing Director · Dec 14, 2017 – Oct 22, 2019 · Past
Aaron DavidsonDirector · May 7, 2014 – May 13, 2014 · Past
John A LathamChief Scientific Officer · May 7, 2014 – Feb 6, 2019 · Past
Timothy M WhitakerChief Medical Officer · Jun 20, 2016 – Jan 27, 2017 · Past

Open People

Log in to ask 6ix AI your own questions about Alder BioPharmaceuticals Inc.